AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.
AbbVie (ABBV) said it has received FDA approval for the combination antibiotic treatment Emblaveo, which was co-developed ...
The following is a summary of “Bacteriophage therapy in women with chronic recurrent cystitis caused by multidrug-resistant bacteria: A prospective, observational, comparative study,” published in the ...
The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.
Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.
An offensive by M23 fighters is disrupting health services and displacing people in a region already beset by health ...
The woman, who goes by Suitable-Mission7422 and is from Pennsylvania, spoke to Newsweek about the kitchen mishap. The 37-year ...
Woman's World on MSN26m
Flu Symptoms Worsening? A Doctor Shares the Signs It Could Be PneumoniaWintertime unfortunately means cold and flu season. And for the estimated 40 million people who get the flu each year, it can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback